FDA Approves Unknown Drug — ZYDUS LIFESCIENCES

# FDA Approves Zydus Lifesciences Generic Drug Application Zydus Lifesciences has received FDA approval for ANDA217815, expanding the company's generic drug portfolio and positioning it to capture additional market share in the competitive generics segment. The approval strengthens Zydus' presence in the U.S. pharmaceutical market and is expected to provide cost-effective treatment alternatives to patients while contributing to the company's revenue growth.